Disclosed herein is the design of an unprecedented electrophilic rhodium enalcarbenoid which results from rhodium(II)-catalyzed decomposition of a new class of enaldiazo compounds. The synthetic utility of these enalcarbenoids has been successfully demonstrated in the first transition-metal-catalyzed [4+2] benzannulation of pyrroles, thus leading to substituted indoles. The new benzannulation has been applied to the efficient synthesis of the natural product leiocarpone as well as a potent adipocyte fatty-acid binding protein inhibitor.
A novel Rh(ii)/Brønsted acid catalyzed tandem benzannulation of oxindoles with enaldiazo carbonyls led to the formation of valuable 1-hydroxy-2-acylcarbazoles. This reaction is proposed to involve a formal insertion of a rhodium enalcarbenoid into an oxindole sp(2) C-O bond, an oxa-Michael addition, Friedel-Crafts reaction and a semipinacol type 1,2-carbonyl migration.
Disclosed herein is the design of an unprecedented electrophilic rhodium enalcarbenoid which results from rhodium(II)‐catalyzed decomposition of a new class of enaldiazo compounds. The synthetic utility of these enalcarbenoids has been successfully demonstrated in the first transition‐metal‐catalyzed [4+2] benzannulation of pyrroles, thus leading to substituted indoles. The new benzannulation has been applied to the efficient synthesis of the natural product leiocarpone as well as a potent adipocyte fatty‐acid binding protein inhibitor.
S. Katukojvala et al. describe in their Communication on the direct [4+2] benzannulation of pyrroles to indoles by using a rhodium enalcarbenoid generated by rhodium(II)‐catalyzed decomposition of enaldiazo compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.